Review Papers Claim by Claim

What the data show (evidence-backed claims)

• Synthesis & photophysics: Divalent tweezers (TWAAP0–4, TWAB1–2) synthesized by iterative CuAAC, show >10 reversible switching cycles, AAP photoswitches give near-quantitative E/Z control and long Z half-lives in water — enabling repeated toggling without photodegradation Synthesis and photophysics (paper)
• Biophysical binding: SPR of immobilized (inactive) Taspase 1 shows low-micromolar KD for several AAP tweezers with isomer-dependent ka/kd differences (e.g., TWAAP0: ka_E≈1.04×10^3 M^-1s^-1, kd_E≈7.43×10^-4 s^-1; kd_Z≈3.22×10^-3 s^-1) implying the E isomer forms a longer-lived complex SPR kinetics (paper)
• Loop binding & PPI interference: Cy5-labeled loop fluorescence titrations and anisotropy competition indicate nanomolar–submicromolar loop binding (loop KD ~64±20 nM; ditopic tweezers KD down to ~200 nM) and competitive impairment of Importin α binding; pull-down assays show construct-dependent PPI disruption (notably TWAAP3 shows E/Z differences in pull-down) Loop binding & PPI data (paper)
• Functional inhibition: Recombinant cleavage assay (GST-MLL CS2 substrate) demonstrates concentration-dependent inhibition with IC50 ≈20–50 µM across the series; longer-spacer AAP tweezers (TWAAP0, 1, 4) show stronger inhibition in the E configuration (≈1.5–1.7× more potent at 50 µM) consistent with MD-bridging occlusion of substrate access Cleavage assay & MD (paper)

Critical strengths

• Complete experimental pipeline: synthesis, photophysics, SPR, fluorescence, 15N-HSQC mapping, enzymatic functional readout, and MD — multi-method corroboration strengthens mechanistic inference Full-method coverage (paper)
• Use of AAP switches leverages modern photoswitch advantages (high photostationary states, long Z lifetimes in water), improving practical toggling for biochemical assays AAP choice and performance (paper)

Key limitations & blindspots (what weakens claims)

1. No cellular or in vivo validation: All data are in vitro (purified proteins, peptides, and MD). Cellular uptake, phototoxicity, off-target lysine binding in complex proteomes, or functional rescue experiments are absent — critical for therapeutic claims or biological relevance In vitro scope (paper)
2. SPR immobilization artifacts: SPR used an inactive Taspase 1 covalently coupled to a matrix-free chip; orientation heterogeneity and covalent coupling near the loop could alter apparent kinetics (authors acknowledge this), and using inactive enzyme may change loop accessibility compared to active, dynamic enzyme forms SPR caveats (paper)
3. Assay discordance / nonspecific binding: Pull-down assays showed nonspecific bead binding for some tweezers (except TWAAP3), complicating direct comparison of PPI disruption; loop peptide assays may not represent loop orientation in the full protein — these differences produce inconsistent E/Z effects across assays Assay discrepancies (paper)
4. Quantitative gaps in main text: Some numeric values (full KD table, complete E/Z PSS numbers for every construct) are located in SI rather than main text; while acceptable, it makes rapid cross-technique comparisons harder for readers without SI access Data location (paper)

Context & prior art

Inserting photoswitches into ligands and assemblies is a growing field; reviews have highlighted the need for visible-addressable, stable switches — AAP chemistry addresses several of these historical limitations (better PSS, longer cis/Z lifetimes) and the authors place their work within photopharmacology/supramolecular PPI inhibition literature Photoswitch review (context)

Conclusions — balanced synthesis

Strength of evidence: strong for a well-documented in vitro proof-of-principle that AAP-linked divalent tweezers can be photomodulated to alter binding kinetics and inhibit Taspase 1 cleavage via steric bridging in the E state; mechanistic model (bridging of lysines flanking the active site) is plausible and supported by orthogonal data (SPR, NMR, cleavage assays, MD) Integrated evidence (paper)

What would change my confidence: demonstration of the same photoregulated inhibition in cells (showing cellular delivery, selectivity, light-activation without toxicity), mutational mapping showing loss of effect when key lysines are replaced, or orthogonal structural evidence (e.g., cryo-EM or crosslinking-MS) of E-isomer bridging across active-site lysines would strongly increase confidence; conversely, nonspecific proteome-wide lysine binding or phototoxicity would weaken translational prospects.

How to strengthen / next experiments (practical roadmap)

1. Cellular assay: express WT Taspase 1 and a cleavage reporter in mammalian cells; deliver tweezers (optimize formulation/vehicle), perform spatially patterned irradiation (520 nm vs 365 nm), and quantify cleavage and localization; include toxicity and off-target proteome lysine profiling.
2. Mutational test: mutate target lysines flanking the active site (K→A or K→R) and evaluate whether E-isomer inhibition is lost — directly tests bridging hypothesis.
3. Crosslinking-MS or cryo-EM: attempt to capture tweezers bound to Taspase 1 (E-state) to obtain direct structural evidence of bridging over the active site.
4. Proteome-wide selectivity: incubate tweezers with cell lysate ± light, then use enrichment or MS to identify predominant protein targets and check off-target risk.

One-line actionable improvement for this review

Provide cellular validation + mutational loss-of-function to decisively link E-isomer bridging to functional inhibition and to quantify selectivity and phototoxicity in biological context.